申请人:COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
公开号:US20160185759A1
公开(公告)日:2016-06-30
The patent discloses novel indazole compounds of general formula 1 and analogues thereof, use thereof for the treatment of diabetes, diabetic complications, cardiovascular dysfuntion or related diseases, pharmaceutical compositions comprising them and processes for their preparation.
该专利披露了一种新型的吲唑化合物,其通式为1和类似物,以及其在糖尿病、糖尿病并发症、心血管功能障碍或相关疾病的治疗中的应用,包括它们的制药组合物和制备过程。